Cutler Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-8,400
Closed -$11K 4777
2020
Q3
$11K Sell
8,400
-800
-9% -$33.9K ﹤0.01% 2890
2020
Q2
$98K Sell
9,200
-11,500
-56% -$501K 0.01% 1317
2020
Q1
$57K Buy
+20,700
New +$744K ﹤0.01% 1644
2019
Q3
Sell
-10,000
Closed -$16K 4040
2019
Q2
$16K Buy
+10,000
New +$292K ﹤0.01% 2356
2017
Q3
Sell
-4,000
Closed -$5K 5823
2017
Q2
$5K Buy
+4,000
New +$85K ﹤0.01% 4790
2016
Q1
Sell
-9,100
Closed -$3K 6447
2015
Q4
$3K Buy
+9,100
New +$188K ﹤0.01% 5219

Other funds holding ATRC

Cutler Group's ATRC Position: Q2 2021 in Review

Cutler Group sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 3,500 shares — an estimated $229K sold.

Cutler Group first reported a position in ATRC in Q2 2016 and held it in 5 quarters. The position peaked at $339K in Q1 2020. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

  • Cutler Group reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 3,500 AtriCure shares in Q2 2021, an estimated $229K.
  • Cutler Group first reported a position in AtriCure in Q2 2016 and held it in 5 quarters.
  • Cutler Group's AtriCure position peaked at $339K in Q1 2020.
  • 212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.